Novo Nordisk shares plunged in early trading after the company pledged to launch more than five blockbuster drugs and generate more than $23 billion in new sales, disappointing investors seeking a clearer turnaround plan.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
